These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36650429)

  • 21. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry.
    Vij V; Piayda K; Nelles D; Gloekler S; Galea R; Fürholz M; Meier B; Valgimigli M; O'Hara G; Arzamendi D; Agudelo V; Asmarats L; Freixa X; Flores-Umanzor E; De Backer O; Sondergaard L; Nombela-Franco L; McInerney A; Korsholm K; Nielsen-Kudsk JE; Afzal S; Zeus T; Operhalski F; Schmidt B; Montalescot G; Guedeney P; Iriart X; Miton N; Saw J; Gilhofer T; Fauchier L; Veliqi E; Meincke F; Petri N; Nordbeck P; Ognerubov D; Merkulov E; Cruz-González I; Gonzalez-Ferreiro R; Bhatt DL; Laricchia A; Mangieri A; Omran H; Schrickel JW; Rodes-Cabau J; Sievert H; Nickenig G; Sedaghat A
    Clin Res Cardiol; 2022 Nov; 111(11):1276-1285. PubMed ID: 35849156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left Atrial Appendage Closure Versus Oral Anticoagulation in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Al-Abcha A; Saleh Y; Elsayed M; Elshafie A; Herzallah K; Baloch ZQ; Banga S; Rayamajhi S; Abela GS
    Cardiovasc Revasc Med; 2022 Mar; 36():18-24. PubMed ID: 33903038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First results of the Brazilian Registry of Percutaneous Left Atrial Appendage Closure.
    Guérios ÊE; Chamié F; Montenegro M; Saad EB; Brito FS; Caramori PA; Simões LC; Oliveira FRA; Giuliano LC; Tavares CMDF
    Arq Bras Cardiol; 2017 Nov; 109(5):440-447. PubMed ID: 29069203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention.
    Yu Y; Xu J; Wang L; Ye Z; Chen Z; Chen F
    BMC Cardiovasc Disord; 2022 Oct; 22(1):433. PubMed ID: 36192682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of incomplete device endothelialization after left atrial appendage closure.
    Xu J; Chen CZ; Xing J; Wang L; Tao YR; Yang B; Zhang Q; Shen YL; Hu JQ
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):451-459. PubMed ID: 36136204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Outcomes of Mortality, Readmissions, and Ischemic Stroke Among Medicare Patients Undergoing Left Atrial Appendage Closure via Implanted Device.
    Kabra R; Girotra S; Vaughan Sarrazin M
    JAMA Netw Open; 2019 Oct; 2(10):e1914268. PubMed ID: 31664447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous left atrial appendage closure in patients with hypertrophic cardiomyopathy and persistent atrial fibrillation: 3-year-followed case series.
    Liu Y; Chen C; Chen Y; Su X; Li Z; Chen Y
    Medicine (Baltimore); 2023 Apr; 102(17):e33646. PubMed ID: 37115077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left atrial appendage closure for stroke prevention in atrial fibrillation: Final report from the French left atrial appendage closure registry.
    Teiger E; Thambo JB; Defaye P; Hermida JS; Abbey S; Klug D; Juliard JM; Spaulding C; Armero S; Champagnac D; Bhugaloo H; Ternacle J; Lellouche N; Audureau E; Le Corvoisier P;
    Catheter Cardiovasc Interv; 2021 Oct; 98(4):788-799. PubMed ID: 34051135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
    Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
    Nefrologia (Engl Ed); 2022; 42(3):290-300. PubMed ID: 36210618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Safety and efficacy of percutaneous left atrial appendage closure in nonvalvular atrial fibrillation patients with left atrial spontaneous echocardiographic contrast].
    Wang Z; Wang BH; Chu HM; Fu GH; Yu F; Zhang SM
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):950-955. PubMed ID: 33789377
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-Term Efficacy and Safety of Left Atrial Appendage Closure Procedures.
    Zadori A; Kis Z; Toth T; Szigeti M; Temesvari A; Fontos G; Nyolczas N; Andreka P
    Int Heart J; 2023 Mar; 64(2):188-195. PubMed ID: 36927928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of individual stroke risk on outcome after Amplatzer left atrial appendage closure in patients with atrial fibrillation.
    Häner JD; Fürholz M; Kleinecke C; Galea R; Streit SR; Fankhauser M; Cherni T; Valgimigli M; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1002-E1010. PubMed ID: 33022121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
    Takeda K; Tsuboko Y; Iwasaki K
    Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion.
    Li W; Gao R; Zhao J; Ren Y; Chen G; Zhu J; Jin K; Zhu L; Ruan Z
    Ann Palliat Med; 2022 Jan; 11(1):201-209. PubMed ID: 35144411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
    J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E
    Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epicardial standalone left atrial appendage clipping for prevention of ischemic stroke in patients with atrial fibrillation contraindicated for oral anticaogulation.
    Branzoli S; Marini M; Guarracini F; Pederzolli C; Pomarolli C; D'Onghia G; Centonze M; Fantinel M; Corsini F; Bonmassari R; Graffigna A; La Meir M
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2187-2191. PubMed ID: 32495408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.